{
  "meta": {
    "title": "Acute_Kidney_Injury",
    "url": "https://brainandscalpel.vercel.app/acute-kidney-injury-57649849.html",
    "scrapedAt": "2025-11-29T18:25:04.976Z"
  },
  "questions": [
    {
      "id": 20359,
      "choices": [
        {
          "id": 81397,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Elevated serum creatinine kinase (CK) </span></span></span></p>"
        },
        {
          "id": 81398,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Hypercalcemia </span></span></span></p>"
        },
        {
          "id": 81399,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Elevated parathyroid hormone (PTH) </span></span></span></p>"
        },
        {
          "id": 81400,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Hypokalemia</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 55-year-old patient with long-standing type 2 diabetes presents with fatigue, pruritus, and elevated creatinine. Renal ultrasound shows bilaterally small kidneys measuring 7 cm in length. Which of the following laboratory findings would best support a diagnosis of CKD rather than acute kidney injury (AKI)?</span></span></p>",
      "unique_key": "Q2818045",
      "question_audio": null,
      "question_video": null,
      "map_id": 20356,
      "difficulty_level": "difficult",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. C) Elevated parathyroid hormone (PTH)</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">In CKD, decreased production of calcitriol leads to secondary hyperparathyroidism, characterized by elevated PTH levels. Small kidneys on ultrasound suggest chronicity</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Elevated serum creatinine kinase (CK)</span></strong><span style=\"font-size:12.0pt\">: Elevated CK is primarily seen in muscle damage, not CKD. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Hypercalcemia</span></strong><span style=\"font-size:12.0pt\">: CKD often leads to <em>hypocalcemia</em> (low calcium) due to impaired vitamin D metabolism, not hypercalcemia. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Hypokalemia</span></strong><span style=\"font-size:12.0pt\">: Hypokalemia is not a primary feature of CKD, although it can occur in later stages due to medication use or other factors.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational objective</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">CKD is characterized by a gradual decline in kidney function over months or years, while AKI is a sudden onset of kidney dysfunction. Elevated parathyroid hormone (PTH) is a key laboratory marker for CKD due to secondary hyperparathyroidism caused by impaired vitamin D metabolism and phosphate retention.</span></span></span></p>",
      "correct_choice_id": 81399,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20360,
      "choices": [
        {
          "id": 81401,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Sudden onset of flank pain and hematuria</span></span></span></p>"
        },
        {
          "id": 81402,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">History of recent contrast dye exposure </span></span></span></p>"
        },
        {
          "id": 81403,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Hyperkalemia and metabolic acidosis </span></span></span></p>"
        },
        {
          "id": 81404,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Progressive worsening of anemia over several months</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following clinical presentations would further support a diagnosis of chronic kidney disease (CKD) rather than acute kidney injury (AKI)?</span></span></p>",
      "unique_key": "Q3107817",
      "question_audio": null,
      "question_video": null,
      "map_id": 20357,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. D) Progressive worsening of anemia over several months</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Chronic kidney disease (CKD) is a gradual loss of kidney function over time, often associated with long-standing medical conditions like diabetes and hypertension. The presentation of fatigue, edema, and foamy urine (indicating proteinuria) suggests nephrotic syndrome, a common complication of CKD. The ultrasound findings of normal-sized kidneys with increased echogenicity are consistent with chronic parenchymal damage. The progressive worsening of anemia is also a classic feature of CKD, as declining kidney function leads to reduced erythropoietin production.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Sudden onset of flank pain and hematuria</span></strong><span style=\"font-size:12.0pt\">:<strong> </strong>This presentation is more suggestive of an acute process, such as kidney stones or a urinary tract infection. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. History of recent contrast dye exposure</span></strong><span style=\"font-size:12.0pt\">: Contrast-induced nephropathy is an acute kidney injury that typically occurs within a few days of exposure to contrast dye. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Hyperkalemia and metabolic acidosis</span></strong><span style=\"font-size:12.0pt\">: While these electrolyte imbalances can occur in both AKI and CKD, they are more commonly associated with acute renal failure due to the rapid decline in kidney function.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational objective</span></u></strong><strong><span style=\"font-size:12.0pt\">: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">CKD typically presents with a gradual onset of symptoms such as fatigue, edema, and foamy urine, along with progressive anemia due to reduced erythropoietin production. In contrast, AKI presents with a sudden onset of symptoms like flank pain, hematuria, or recent exposure to nephrotoxic agents.</span></span></span></p>",
      "correct_choice_id": 81404,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20361,
      "choices": [
        {
          "id": 81405,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">Acute tubular necrosis (ATN) </span></span></span></p>"
        },
        {
          "id": 81406,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Prerenal azotemia </span></span></span></p>"
        },
        {
          "id": 81407,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Acute interstitial nephritis (AIN) </span></span></span></p>"
        },
        {
          "id": 81408,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Postrenal obstruction</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 70-year-old man with a history of hypertension presents with acute onset oliguria and elevated creatinine. His blood pressure is 90/60 mmHg, and he reports recent episodes of diarrhea and vomiting. Which of the following is the most likely cause of his AKI?</span></span></p>",
      "unique_key": "Q6552079",
      "question_audio": null,
      "question_video": null,
      "map_id": 20358,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. B) Prerenal azotemia</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The patient&#39;s history of hypotension, dehydration (from diarrhea and vomiting), and oliguria strongly suggests prerenal AKI, where decreased renal perfusion is the primary cause.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Option A.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>Acute tubular necrosis (ATN):</strong> While possible, it&#39;s less likely in this scenario without a history of nephrotoxic drug exposure or prolonged hypotension</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Option C.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>Acute interstitial nephritis (AIN):</strong> This would typically present with fever, rash, or other signs of allergic reaction.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Option D.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>Postrenal obstruction:</strong> Less likely given the absence of urinary symptoms suggestive of obstruction</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">To understand the different causes of acute kidney injury (AKI) and to be able to identify prerenal azotemia as the most likely cause in a patient with hypotension, dehydration, and oliguria. Prerenal azotemia is a functional AKI caused by decreased blood flow to the kidneys, often due to volume depletion or low blood pressure.</span></span></span></p>",
      "correct_choice_id": 81406,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20362,
      "choices": [
        {
          "id": 81409,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Metformin </span></span></span></p>"
        },
        {
          "id": 81410,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Furosemide </span></span></span></p>"
        },
        {
          "id": 81411,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Lisinopril </span></span></span></p>"
        },
        {
          "id": 81412,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Aspirin</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 65-year-old male with a history of heart failure and diabetes mellitus is admitted to the hospital with worsening shortness of breath and leg edema. His serum creatinine has increased from 1.2 mg/dL to 2.5 mg/dL over the past 2 days. Which of the following medications is most likely to have precipitated this acute kidney injury?</span></span></p>",
      "unique_key": "Q3927851",
      "question_audio": null,
      "question_video": null,
      "map_id": 20359,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. C) Lisinopril</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Lisinopril, an angiotensin-converting enzyme (ACE) inhibitor, is a common culprit for AKI in patients with pre-existing cardiac or renal dysfunction. ACE inhibitors can decrease glomerular filtration rate (GFR) by reducing efferent arteriolar resistance, particularly in patients with decreased renal perfusion.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Metformin</span></strong><span style=\"font-size:12.0pt\">:&nbsp;Metformin is not directly nephrotoxic but can cause lactic acidosis, which can worsen AKI.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B.</span></strong> <strong><span style=\"font-size:12.0pt\">Furosemide</span></strong><span style=\"font-size:12.0pt\">:<strong> </strong>Furosemide, a diuretic, might worsen AKI if dehydration is the underlying cause.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Aspirin</span></strong><span style=\"font-size:12.0pt\">:<strong> </strong>Aspirin is not typically associated with AKI unless taken in very high doses.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">To recognize that angiotensin-converting enzyme (ACE) inhibitors, such as lisinopril, can precipitate acute kidney injury (AKI) in patients with pre-existing cardiac or renal dysfunction. ACE inhibitors can decrease glomerular filtration rate (GFR) by reducing efferent arteriolar resistance, particularly in patients with decreased renal perfusion.</span></span></span></p>",
      "correct_choice_id": 81411,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20363,
      "choices": [
        {
          "id": 81413,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A 40-year-old with baseline creatinine of 1.2 mg/dL, current creatinine of 2.6 mg/dL, and urine output of 0.4 mL/kg/hour for 18 hours. </span></span></span></p>"
        },
        {
          "id": 81414,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A 25-year-old with a baseline creatinine of 0.9 mg/dL, current creatinine of 1.8 mg/dL, and anuria for 14 hours. </span></span></span></p>"
        },
        {
          "id": 81415,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A 50-year-old with a baseline creatinine of 0.9 mg/dL, current creatinine of 1.5 mg/dL, and anuria for 10 hours.</span></span></span></p>"
        },
        {
          "id": 81416,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A 15-year-old with a decrease in eGFR to 30 mL/min/1.73 m&sup2;.</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following scenarios would classify a patient as having Stage 3 AKI?</span></span></p>",
      "unique_key": "Q9569965",
      "question_audio": null,
      "question_video": null,
      "map_id": 20360,
      "difficulty_level": "difficult",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. D) A 15-year-old with a decrease in eGFR to 30 mL/min/1.73 m&sup2;.</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/12/screenshot-2024-08-12-144229.png\" style=\"height:594px; width:1000px\" /></p>",
      "correct_choice_id": 81416,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "CriteriaBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20364,
      "choices": [
        {
          "id": 81417,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">Plasma NGAL </span></span></span></p>"
        },
        {
          "id": 81418,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">Urinary KIM-1 </span></span></span></p>"
        },
        {
          "id": 81419,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">Plasma suPAR </span></span></span></p>"
        },
        {
          "id": 81420,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Urinary TIMP-2 and IGFBP7</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 45-year-old woman with a history of diabetes mellitus presents with nausea, vomiting, and oliguria. Her serum creatinine is 2.5 mg/dL, and her urine microscopy shows muddy brown granular casts. Which of the following biomarkers would be most helpful in confirming the diagnosis of acute tubular necrosis (ATN)?</span></span></p>",
      "unique_key": "Q3681912",
      "question_audio": null,
      "question_video": null,
      "map_id": 20361,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. B) Urinary KIM-1</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">KIM-1 is a transmembrane protein that is abundantly expressed in proximal tubular cells injured by ischemia or nephrotoxins. Muddy brown granular casts are a classic finding in ATN, and the presence of KIM-1 in the urine would further support this diagnosis. While NGAL can also be elevated in ATN, it is less specific than KIM-1. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Plasma NGAL</span></strong><span style=\"font-size:12.0pt\">: While NGAL is an early marker for AKI, it&#39;s not specific for ATN and can be elevated in other causes of kidney injury.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Plasma suPAR</span></strong><span style=\"font-size:12.0pt\">: suPAR is more useful in predicting the risk of developing AKI, not confirming ATN.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Urinary TIMP-2 and IGFBP7</span></strong><span style=\"font-size:12.0pt\">: These biomarkers are primarily used to predict the risk of severe AKI, not to diagnose the specific cause like ATN</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">To understand the role of urinary biomarkers, specifically KIM-1, in confirming the diagnosis of acute tubular necrosis (ATN). ATN is a common cause of acute kidney injury (AKI), characterized by damage to the renal tubules. Urinary KIM-1 is a highly sensitive and specific biomarker for ATN, as it is released from injured proximal tubular cells.</span></span></span></p>",
      "correct_choice_id": 81418,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20365,
      "choices": [
        {
          "id": 81421,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Antibiotics alone </span></span></span></p>"
        },
        {
          "id": 81422,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Intravenous fluids and observation </span></span></span></p>"
        },
        {
          "id": 81423,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Percutaneous nephrostomy tube placement </span></span></span></p>"
        },
        {
          "id": 81424,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Ureteral stent placement</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 65-year-old woman with a history of recurrent urinary tract infections presents with fever, chills, flank pain, and anuria. Ultrasound reveals bilateral hydronephrosis. Which of the following is the most appropriate next step in management?</span></span></p>",
      "unique_key": "Q7019307",
      "question_audio": null,
      "question_video": null,
      "map_id": 20362,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. C) Percutaneous nephrostomy tube placement</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The clinical presentation suggests obstructive uropathy with possible infection. Anuria and bilateral hydronephrosis indicate a significant obstruction. While antibiotics are important for treating the infection, immediate decompression of the urinary tract is critical to prevent further kidney damage. Percutaneous nephrostomy tube placement is the most expedient way to achieve this in a patient with anuria. Ureteral stents might be considered later, but the urgency of the situation necessitates faster decompression.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Antibiotics alone</span></strong><span style=\"font-size:12.0pt\">: Antibiotics alone will not address the underlying obstruction causing the anuria and potential kidney damage. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Intravenous fluids and observation</span></strong><span style=\"font-size:12.0pt\">: Intravenous fluids may worsen hydronephrosis and observation is not appropriate in the setting of anuria. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Ureteral stent placement</span></strong><span style=\"font-size:12.0pt\">: Ureteral stent placement, while a possible treatment, is not as immediate or effective as nephrostomy in relieving anuria</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational objective</span></u></strong><strong><span style=\"font-size:12.0pt\">: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Obstructive uropathy can quickly lead to irreversible kidney damage, and immediate intervention with a percutaneous nephrostomy tube is often necessary to preserve renal function.</span></span></span></p>",
      "correct_choice_id": 81423,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20366,
      "choices": [
        {
          "id": 81425,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The patient is at high risk of developing severe AKI requiring dialysis. </span></span></span></p>"
        },
        {
          "id": 81426,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The patient is at moderate risk of AKI, and close monitoring of renal function is necessary. </span></span></span></p>"
        },
        {
          "id": 81427,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The patient is at low risk of severe AKI, as transient ischemia in a normal kidney is unlikely to cause significant damage. </span></span></span></p>"
        },
        {
          "id": 81428,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The patient&#39;s risk of AKI cannot be determined without knowing their baseline creatinine level.</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 60-year-old patient with no prior kidney disease undergoes elective abdominal aortic aneurysm repair requiring cross-clamping of the aorta above the renal arteries. The procedure lasts 45 minutes, and the patient&#39;s blood pressure is well-maintained throughout. Which of the following statements regarding the patient&#39;s risk of acute kidney injury (AKI) is most accurate?</span></span></p>",
      "unique_key": "Q8763567",
      "question_audio": null,
      "question_video": null,
      "map_id": 20363,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. C) The patient is at low risk of severe AKI, as transient ischemia in a normal kidney is unlikely to cause significant damage.</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Healthy kidneys can tolerate short ischemia due to their blood supply, self-regulation, and repair mechanisms. The patient&#39;s healthy kidneys and brief ischemia during surgery suggest a low risk of severe AKI.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. The patient is at high risk of developing severe AKI requiring dialysis</span></strong><span style=\"font-size:12.0pt\">: Severe AKI requiring dialysis is unlikely after a brief, well-managed ischemic event in a healthy individual. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. The patient is at moderate risk of AKI, and close monitoring of renal function is necessary</span></strong><span style=\"font-size:12.0pt\">: While some degree of AKI is possible, it is unlikely to be moderate in this specific scenario with a normal kidney and controlled blood pressure. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. The patient&#39;s risk of AKI cannot be determined without knowing their baseline creatinine level</span></strong><span style=\"font-size:12.0pt\">: While baseline creatinine is helpful, the focus here is the effect of transient ischemia on a normal kidney, not the pre-existing renal function.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational objective</span></u></strong><strong><span style=\"font-size:12.0pt\">: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Factors like adequate blood supply, autoregulation mechanisms, and cellular repair processes contribute to the kidney&#39;s resilience to transient ischemic events.</span></span></span></p>",
      "correct_choice_id": 81427,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20367,
      "choices": [
        {
          "id": 81429,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">FeNa &lt; 1% </span></span></span></p>"
        },
        {
          "id": 81430,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">FeNa 1-2% </span></span></span></p>"
        },
        {
          "id": 81431,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">FeNa 2-3% </span></span></span></p>"
        },
        {
          "id": 81432,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">FeNa &gt; 3%</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 70-year-old male with a history of chronic heart failure (CHF) on furosemide presents with worsening dyspnea, oliguria, hypotension, and elevated serum creatinine and blood urea nitrogen (BUN) levels. Urinalysis demonstrates dilute urine. The treating physician is suspecting Pre-renal AKI rather than a ATN, which of the following findings supports his diagnosis? </span></span></p>",
      "unique_key": "Q6882057",
      "question_audio": null,
      "question_video": null,
      "map_id": 20364,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. A) FeNa &lt; 1%</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Prerenal AKI arises from reduced renal perfusion, often due to conditions like heart failure or dehydration. In this scenario, the kidneys attempt to conserve sodium and water, leading to a low FeNa (&lt;1%). The patient&#39;s history of CHF, hypotension, and dilute urine on urinalysis are all consistent with prerenal AKI.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. FeNa 1-2%:</span></strong><span style=\"font-size:12.0pt\">&nbsp;This is an indeterminate FeNa range, not definitively diagnostic of either prerenal AKI or ATN.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. FeNa 2-3%:</span></strong><span style=\"font-size:12.0pt\">&nbsp;This value suggests intrinsic renal injury, more characteristic of ATN where the tubules are unable to effectively reabsorb sodium.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. FeNa &gt; 3%:</span></strong><span style=\"font-size:12.0pt\">&nbsp;A FeNa greater than 3% strongly suggests intrinsic renal injury, likely ATN, where the tubules have lost their reabsorptive capacity.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational objective</span></u></strong><strong><span style=\"font-size:12.0pt\">: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A low FeNa (&lt;1%) is a hallmark of prerenal AKI, reflecting the kidney&#39;s attempt to conserve sodium in response to decreased renal perfusion.</span></span></span></p>",
      "correct_choice_id": 81429,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20368,
      "choices": [
        {
          "id": 81433,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Terlipressin </span></span></span></p>"
        },
        {
          "id": 81434,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Octreotide </span></span></span></p>"
        },
        {
          "id": 81435,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Midodrine </span></span></span></p>"
        },
        {
          "id": 81436,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Albumin</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following medications has been shown to potentially prevent AKI in patients with cirrhosis and spontaneous bacterial peritonitis treated with antibiotics?</span></span></p>",
      "unique_key": "Q4334647",
      "question_audio": null,
      "question_video": null,
      "map_id": 20365,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. D) Albumin</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Studies have shown that albumin administration can help prevent AKI in patients with SBP undergoing antibiotic treatment. Albumin may improve renal perfusion and reduce inflammation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Terlipressin</span></strong><span style=\"font-size:12.0pt\">:<strong> </strong>Terlipressin works by constricting blood vessels in the splanchnic circulation, which can improve blood flow to the kidneys.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">&nbsp;<strong>Option B. Octreotide</strong>:<strong> </strong>Octreotide reduces splanchnic blood flow and inhibits the release of hormones that worsen kidney function.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Midodrine</span></strong><span style=\"font-size:12.0pt\">:<strong> </strong>Midodrine is a vasopressor that helps to increase blood pressure and improve renal perfusion.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">While these medications may indirectly improve kidney function in some patients, they are not the first-line therapy for preventing AKI in SBP. Albumin administration, on the other hand, has been shown to be more effective in this specific context.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">To understand that albumin administration is an effective intervention for preventing acute kidney injury (AKI) in patients with cirrhosis and spontaneous bacterial peritonitis (SBP) treated with antibiotics. Albumin helps improve renal perfusion and reduce inflammation, thereby mitigating the risk of AKI in this specific population.</span></span></span></p>",
      "correct_choice_id": 81436,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20369,
      "choices": [
        {
          "id": 81437,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Terlipressin and albumin </span></span></span></p>"
        },
        {
          "id": 81438,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Octreotide and midodrine </span></span></span></p>"
        },
        {
          "id": 81439,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Continuous renal replacement therapy (CRRT) </span></span></span></p>"
        },
        {
          "id": 81440,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Liver transplantation</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 58-year-old patient with decompensated cirrhosis and refractory ascites presents with oliguria, worsening creatinine, and a low urine sodium concentration (&lt;10 mEq/L). Despite aggressive volume resuscitation with albumin, their renal function continues to decline. Which of the following represents the definitive treatment for their underlying condition?</span></span></p>",
      "unique_key": "Q3922664",
      "question_audio": null,
      "question_video": null,
      "map_id": 20366,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. D) Liver transplantation</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Hepatorenal syndrome (HRS) is a serious complication of advanced cirrhosis characterized by renal failure without structural kidney damage. The definitive treatment for HRS is liver transplantation, as it addresses the underlying liver dysfunction driving the syndrome.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Terlipressin and albumin:</span></strong><span style=\"font-size:12.0pt\">&nbsp;These are vasoconstrictor medications used as a bridge to transplant in HRS,&nbsp;providing temporary improvement in renal function.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Octreotide and midodrine:</span></strong><span style=\"font-size:12.0pt\">&nbsp;This combination is another pharmacologic therapy used to manage HRS,&nbsp;but it doesn&#39;t address the root cause.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Continuous renal replacement therapy (CRRT):</span></strong><span style=\"font-size:12.0pt\">&nbsp;While CRRT can provide temporary support for kidney function,&nbsp;it does not treat the underlying cause of HRS and is not a definitive treatment. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">To recognize that liver transplantation is the definitive treatment for hepatorenal syndrome (HRS), a serious complication of advanced cirrhosis characterized by renal failure. While pharmacological interventions like terlipressin, albumin, octreotide, and midodrine can provide temporary support, they do not address the underlying liver dysfunction that drives HRS.</span></span></span></p>",
      "correct_choice_id": 81440,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20370,
      "choices": [
        {
          "id": 81441,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Reduced renal perfusion due to low cardiac output </span></span></span></p>"
        },
        {
          "id": 81442,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Increased venous congestion leading to renal venous hypertension </span></span></span></p>"
        },
        {
          "id": 81443,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Neurohormonal activation (RAAS, SNS) </span></span></span></p>"
        },
        {
          "id": 81444,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Direct nephrotoxicity of heart failure medications.</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following is NOT a proposed mechanism for the cardiorenal syndrome in ADHF? </span></span></p>",
      "unique_key": "Q6816940",
      "question_audio": null,
      "question_video": null,
      "map_id": 20367,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. A) Reduced renal perfusion due to low cardiac output. </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">In most ADHF cases, cardiac output is preserved, so renal hypoperfusion is not the primary mechanism. The other options (venous congestion, neurohormonal activation, and drug effects) are potential contributors to CRS.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Increased venous congestion leading to renal venous hypertension:</span></strong><span style=\"font-size:12.0pt\"> In ADHF, the heart&#39;s reduced pumping capacity can lead to a backup of blood in the veins, including those draining the kidneys. This increased pressure can impede blood flow through the kidneys, leading to decreased glomerular filtration rate (GFR) and contributing to CRS.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Neurohormonal activation (RAAS, SNS):</span></strong><span style=\"font-size:12.0pt\"> In response to decreased cardiac output, the body activates neurohormonal systems like the renin-angiotensin-aldosterone system (RAAS) and the sympathetic nervous system (SNS). These systems can cause vasoconstriction in the kidneys, further reducing blood flow and contributing to renal dysfunction.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Direct nephrotoxicity of heart failure medications:</span></strong><span style=\"font-size:12.0pt\"> Some medications used to treat heart failure, such as certain diuretics and NSAIDs, can be directly toxic to the kidneys, especially in patients with pre-existing renal dysfunction. This can worsen or precipitate AKI in the context of CRS.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">To understand the pathophysiology of cardiorenal syndrome (CRS) in acute decompensated heart failure (ADHF), recognizing that reduced renal perfusion due to low cardiac output is NOT a primary mechanism in most cases. Instead, venous congestion, neurohormonal activation, and direct nephrotoxicity of medications are the main contributors to this complex syndrome.</span></span></span></p>",
      "correct_choice_id": 81441,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20371,
      "choices": [
        {
          "id": 81445,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Gadolinium-based contrast agent (GBCA) </span></span></span></p>"
        },
        {
          "id": 81446,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Iodine-based contrast agent </span></span></span></p>"
        },
        {
          "id": 81447,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Barium sulfate </span></span></span></p>"
        },
        {
          "id": 81448,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Air contrast</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A patient with stage 4 CKD on dialysis develops nephrogenic systemic fibrosis (NSF) after an MRI. Which contrast agent was most likely used?</span></span></span></p>",
      "unique_key": "Q4357763",
      "question_audio": null,
      "question_video": null,
      "map_id": 20368,
      "difficulty_level": "difficult",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. A) Gadolinium-based contrast agent (GBCA)</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Gadolinium has been associated with development of nephrogenic systemic fibrosis (NSF) in subjects with advanced kidney disease, but the majority of these cases were associated with group I gadolinium-based contrast media. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Iodine-</span></strong><strong><span style=\"font-size:12.0pt\">based contrast agents:&nbsp;</span></strong><span style=\"font-size:12.0pt\">These are primarily used in X-ray and CT imaging. While they can cause contrast-induced nephropathy (CIN), they are not associated with nephrogenic systemic fibrosis (NSF).</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Barium</span></strong><strong><span style=\"font-size:12.0pt\"> sulfate:&nbsp;</span></strong><span style=\"font-size:12.0pt\">This contrast agent is used for gastrointestinal imaging and is not typically administered intravenously. Thus, it would not be expected to cause NSF, which is related to systemic exposure to contrast agents.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Air contrast</span></strong><strong><span style=\"font-size:12.0pt\">:&nbsp;</span></strong><span style=\"font-size:12.0pt\">This is not a chemical contrast agent, but rather air or carbon dioxide used to enhance the visibility of certain structures in imaging studies. It does not pose a risk of NSF</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">To understand the association between gadolinium-based contrast agents (GBCAs) and nephrogenic systemic fibrosis (NSF) in patients with advanced kidney disease. Recognizing that GBCA exposure is the primary risk factor for NSF is crucial for preventing this debilitating condition.</span></span></span></p>",
      "correct_choice_id": 81445,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20372,
      "choices": [
        {
          "id": 81449,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Administer high-dose furosemide before and after the procedure. </span></span></span></p>"
        },
        {
          "id": 81450,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Use low-osmolar or iso-osmolar contrast media. </span></span></span></p>"
        },
        {
          "id": 81451,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Pretreat with oral N-acetylcysteine. </span></span></span></p>"
        },
        {
          "id": 81452,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Hold metformin for 48 hours before and after the procedure.</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A 65-year-old diabetic patient with chronic kidney disease (eGFR 35 mL/min) is scheduled for a coronary angiogram. Which of the following measures is most likely to prevent contrast-induced nephropathy (CIN)?</span></span></span></p>",
      "unique_key": "Q7686090",
      "question_audio": null,
      "question_video": null,
      "map_id": 20369,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. B) Use low-osmolar or iso-osmolar contrast media.</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Low or iso-osmolar contrast agents are less nephrotoxic than high-osmolar agents and significantly reduce the risk of CIN.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Administer high-dose furosemide before and after the procedure</span></strong><span style=\"font-size:12.0pt\">: Furosemide may actually worsen renal function in this setting.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Pretreat with oral N-acetylcysteine</span></strong><span style=\"font-size:12.0pt\">: N-acetylcysteine has limited evidence for CIN prevention.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Hold metformin for 48 hours before and after the procedure</span></strong><span style=\"font-size:12.0pt\">: Metformin is held due to lactic acidosis risk, not CIN.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">To recognize the importance of using low-osmolar or iso-osmolar contrast media in patients with chronic kidney disease (CKD) to prevent contrast-induced nephropathy (CIN). While other measures like hydration and withholding certain medications are also important, the choice of contrast agent plays a significant role in mitigating the risk of CIN in these patients.</span></span></span></p>",
      "correct_choice_id": 81450,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20373,
      "choices": [
        {
          "id": 81453,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Acute interstitial nephritis </span></span></span></p>"
        },
        {
          "id": 81454,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Contrast-induced nephropathy </span></span></span></p>"
        },
        {
          "id": 81455,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Atheroembolic renal disease </span></span></span></p>"
        },
        {
          "id": 81456,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Cholesterol emboli syndrome</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 72-year-old man presents with livedo reticularis, blue toes, and acute kidney injury (AKI) after undergoing a coronary angiogram. Which of the following is the most likely diagnosis?</span></span></p>",
      "unique_key": "Q2386367",
      "question_audio": null,
      "question_video": null,
      "map_id": 20370,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. C) Atheroembolic renal disease</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The classic triad of livedo reticularis, blue toes (cyanosis), and AKI after a vascular procedure strongly suggests athero-embolic renal disease.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Acute interstitial nephritis</span></strong><span style=\"font-size:12.0pt\">: AIN is not associated with livedo reticularis or blue toes.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Contrast-induced nephropathy</span></strong><span style=\"font-size:12.0pt\">: CIN typically presents within 24-48 hours of contrast exposure, not days later.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Cholesterol emboli syndrome</span></strong><span style=\"font-size:12.0pt\">: While similar,&nbsp;cholesterol emboli syndrome typically lacks renal involvement</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">To recognize the classic presentation of atheroembolic renal disease (AERD), which includes livedo reticularis, blue toes (cyanosis), and acute kidney injury (AKI) following a vascular procedure. This triad of symptoms is highly suggestive of AERD and should prompt further investigation and appropriate management.</span></span></span></p>",
      "correct_choice_id": 81455,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20374,
      "choices": [
        {
          "id": 81457,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Immune-mediated glomerulonephritis </span></span></span></p>"
        },
        {
          "id": 81458,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Renal artery stenosis </span></span></span></p>"
        },
        {
          "id": 81459,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Renal tubular obstruction by myoglobin casts </span></span></span></p>"
        },
        {
          "id": 81460,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Crystal nephropathy</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A patient with rhabdomyolysis develops acute kidney injury (AKI). Which of the following is the most likely mechanism of AKI in this setting?</span></span></p>",
      "unique_key": "Q8642210",
      "question_audio": null,
      "question_video": null,
      "map_id": 20371,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. C) Renal tubular obstruction by myoglobin casts</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Myoglobin released from damaged muscles can precipitate in the renal tubules, forming casts that obstruct urine flow and cause AKI</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Immune-mediated glomerulonephritis:</span></strong><span style=\"font-size:12.0pt\">&nbsp;This is an inflammatory process affecting the glomeruli (filtering units of the kidney) and is not the primary mechanism in rhabdomyolysis-induced AKI.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Renal artery stenosis:</span></strong><span style=\"font-size:12.0pt\">&nbsp;This is a narrowing of the artery supplying the kidney,&nbsp;which can reduce blood flow and cause kidney damage,&nbsp;but it is not directly related to rhabdomyolysis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Crystal nephropathy:</span></strong><span style=\"font-size:12.0pt\">&nbsp;This is caused by the deposition of crystals in the kidneys,&nbsp;most commonly from medications like acyclovir or sulfa drugs,&nbsp;and is not the primary mechanism in rhabdomyolysis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational objective</span></u></strong><strong><span style=\"font-size:12.0pt\">: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The pathophysiology of acute kidney injury (AKI) in rhabdomyolysis, specifically recognizing that renal tubular obstruction by myoglobin casts is the primary mechanism. </span></span></span></p>",
      "correct_choice_id": 81459,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20375,
      "choices": [
        {
          "id": 81461,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Statins </span></span></span></p>"
        },
        {
          "id": 81462,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Amphetamines </span></span></span></p>"
        },
        {
          "id": 81463,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Cocaine </span></span></span></p>"
        },
        {
          "id": 81464,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">All of the above</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following medications is known to increase the risk of rhabdomyolysis?</span></span></p>",
      "unique_key": "Q6014593",
      "question_audio": null,
      "question_video": null,
      "map_id": 20372,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. D) All of the above</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">All of these medications have been associated with increased risk of rhabdomyolysis through various mechanisms. Statins can cause myopathy, amphetamines can cause hyperthermia and dehydration, and cocaine can lead to seizures and hyperthermia, all of which can trigger muscle breakdown. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational objective</span></u></strong><strong><span style=\"font-size:12.0pt\">: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Statins, amphetamines, and cocaine are all associated with an increased risk of rhabdomyolysis, a potentially life-threatening condition characterized by the breakdown of skeletal muscle.</span></span></span></p>",
      "correct_choice_id": 81464,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20376,
      "choices": [
        {
          "id": 81465,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Glomerular crescent formation and fibrinoid necrosis </span></span></span></p>"
        },
        {
          "id": 81466,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Tubular atrophy and interstitial fibrosis </span></span></span></p>"
        },
        {
          "id": 81467,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Interstitial edema and inflammatory infiltrate with predominantly eosinophils </span></span></span></p>"
        },
        {
          "id": 81468,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Thickening of the glomerular basement membrane with immune complex deposits</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 50-year-old patient presents with acute kidney injury (AKI), fever, maculopapular rash, and arthralgias after recently starting a new medication. A renal biopsy is performed. Which of the following HPE findings will be seen in this patient?</span></span></p>",
      "unique_key": "Q6405001",
      "question_audio": null,
      "question_video": null,
      "map_id": 20373,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. C) Interstitial edema and inflammatory infiltrate with predominantly eosinophils</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Acute interstitial nephritis is characterized by inflammation in the kidney interstitium (the space between the tubules). The most common findings on a renal biopsy in AIN are:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Interstitial edema:</span></strong><span style=\"font-size:12.0pt\">&nbsp;Fluid accumulation in the interstitium due to inflammation</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Inflammatory infiltrate:</span></strong><span style=\"font-size:12.0pt\">&nbsp;Predominantly lymphocytes and monocytes,&nbsp;but often with a significant number of eosinophils,&nbsp;which is a distinguishing feature of AIN.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Tubulitis:</span></strong><span style=\"font-size:12.0pt\">&nbsp;Inflammation of the renal tubules</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">These findings together suggest an immune-mediated hypersensitivity reaction, which is the typical cause of AIN.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Glomerular crescent formation and fibrinoid necrosis:</span></strong><span style=\"font-size:12.0pt\">&nbsp;These are characteristic of rapidly progressive glomerulonephritis (RPGN),&nbsp;a different type of kidney disease.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Tubular atrophy and interstitial fibrosis:</span></strong><span style=\"font-size:12.0pt\">&nbsp;These findings are more indicative of chronic kidney disease (CKD) rather than the acute inflammatory process of AIN.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Thickening of the glomerular basement membrane with immune complex deposits:</span></strong><span style=\"font-size:12.0pt\">&nbsp;This is a common feature of immune-complex mediated glomerulonephritis,&nbsp;not AIN.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational objective</span></u></strong><strong><span style=\"font-size:12.0pt\">: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The characteristic histopathological features of acute interstitial nephritis (AIN) on a renal biopsy, which include interstitial edema, inflammatory infiltrate with predominantly eosinophils, and tubulitis. Recognizing these findings is crucial for the accurate diagnosis and management of AIN, a common cause of acute kidney injury (AKI).</span></span></span></p>",
      "correct_choice_id": 81467,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20377,
      "choices": [
        {
          "id": 81469,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Acute glomerulonephritis</span></span></span></p>"
        },
        {
          "id": 81470,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Pyelonephritis</span></span></span></p>"
        },
        {
          "id": 81471,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Acute Interstitial Nephritis</span></span></span></p>"
        },
        {
          "id": 81472,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Acute tubular necrosis</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 25-year-old female presents to the emergency department with fever, flank pain, and dysuria. Urinalysis is performed as part of her evaluation, which is shown in the image. Which of the following is the most likely diagnosis?</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/12/screenshot-2024-08-12-150231.png\" style=\"height:140px; width:300px\" /></span></span></p>",
      "unique_key": "Q2561197",
      "question_audio": null,
      "question_video": null,
      "map_id": 20374,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. B) Pyelonephritis</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The image description suggests the presence of white blood cells (WBCs) in the urine, which is consistent with an infectious process in the urinary tract. The clinical presentation of fever, flank pain, and dysuria, along with the urinalysis findings, most likely points to a diagnosis of pyelonephritis (B), an infection of the kidney typically caused by bacteria that have ascended from the lower urinary tract. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">A. Acute glomerulonephritis</span></strong><span style=\"font-size:12.0pt\">:</span><strong> </strong><span style=\"font-size:12.0pt\">Acute glomerulonephritis</span><span style=\"font-size:12.0pt\"> is usually characterized by hypertension, hematuria with red blood cell casts, proteinuria, and varying degrees of renal insufficiency, which is not consistent with the presented findings.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">C. Acute interstitial nephritis</span></strong><span style=\"font-size:12.0pt\">:</span><strong> </strong><span style=\"font-size:12.0pt\">Acute interstitial nephritis</span><span style=\"font-size:12.0pt\"> typically presents with a rash, fever, and eosinophilia and is often a hypersensitivity reaction to medications. WBC casts may be present, but the clinical symptoms and the absence of medication history make this less likely.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">D. Acute tubular necrosis (ATN)</span></strong><span style=\"font-size:12.0pt\">:</span><strong> </strong><span style=\"font-size:12.0pt\">Acute tubular necrosis (ATN)</span><span style=\"font-size:12.0pt\"> often presents with a history of ischemia or nephrotoxic injury, and the urinalysis would typically show muddy brown casts, not the white blood cell casts indicative of infection.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Pyelonephritis is diagnosed based on the combination of clinical symptoms such as fever, flank pain, and dysuria, along with laboratory findings of white blood cell casts in the urine, indicating an infection that has reached the renal pelvis.</span></span></span></p>",
      "correct_choice_id": 81470,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20378,
      "choices": [
        {
          "id": 81473,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">Prerenal azotemia </span></span></span></p>"
        },
        {
          "id": 81474,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">Acute tubular necrosis (ATN) </span></span></span></p>"
        },
        {
          "id": 81475,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Acute glomerulonephritis </span></span></span></p>"
        },
        {
          "id": 81476,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Postrenal obstruction</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 72-year-old male with hypertension and type 2 diabetes presents with oliguria, weakness, nausea, and recent initiation of a new anti-hypertensive medication. He has elevated creatinine, BUN, and hyperkalemia. Urinalysis slide is shown below. What&rsquo;s the most likely cause of his kidney injury? </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/12/screenshot-2024-08-12-150358.png\" style=\"height:206px; width:300px\" /></span></span></p>",
      "unique_key": "Q5386845",
      "question_audio": null,
      "question_video": null,
      "map_id": 20375,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. B) Acute tubular necrosis (ATN)</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The presence of muddy brown granular casts is a hallmark of ATN. Combined with the patient&#39;s recent medication change (a potential nephrotoxin) and clinical presentation, ATN is the most likely diagnosis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Prerenal azotemia:</span></strong><span style=\"font-size:12.0pt\">&nbsp;While possible given the patient&#39;s history,&nbsp;prerenal AKI usually presents with bland urine sediment and a BUN/creatinine ratio &gt;20:1.&nbsp;The presence of granular casts makes this diagnosis less likely.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Acute glomerulonephritis:</span></strong><span style=\"font-size:12.0pt\">&nbsp;This typically presents with hematuria,&nbsp;proteinuria,&nbsp;and RBC casts.&nbsp;The absence of these findings and the presence of granular casts make this diagnosis less likely.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Postrenal obstruction:</span></strong><span style=\"font-size:12.0pt\">&nbsp;This would likely present with anuria and pain.&nbsp;Ultrasound would be needed to confirm this diagnosis.&nbsp;The presence of granular casts points toward intrinsic renal injury rather than obstruction.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The characteristic findings of acute tubular necrosis (ATN) on urinalysis, which include muddy brown granular casts. These casts, in combination with the patient&#39;s clinical presentation and history (recent medication change, elevated creatinine, BUN, and hyperkalemia), can help distinguish ATN from other causes of acute kidney injury (AKI).</span></span></span></p>",
      "correct_choice_id": 81474,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20379,
      "choices": [
        {
          "id": 81477,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Intermittent hemodialysis </span></span></span></p>"
        },
        {
          "id": 81478,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Continuous renal replacement therapy (CRRT) </span></span></span></p>"
        },
        {
          "id": 81479,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Peritoneal dialysis </span></span></span></p>"
        },
        {
          "id": 81480,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Sustained low-efficiency dialysis (SLED)</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which dialysis modality is most appropriate for a hemodynamically unstable patient with AKI and severe fluid overload?</span></span></p>",
      "unique_key": "Q1330787",
      "question_audio": null,
      "question_video": null,
      "map_id": 20376,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. B) Continuous renal replacement therapy (CRRT)</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">CRRT is the preferred modality for hemodynamically unstable patients as it provides gentle, continuous fluid and solute removal, minimizing the risk of hypotension.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">A. Intermittent hemodialysis</span></strong><span style=\"font-size:12.0pt\">: Intermittent hemodialysis can cause hemodynamic instability in these patients.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">C. Peritoneal dialysis</span></strong><span style=\"font-size:12.0pt\">: Peritoneal dialysis is less efficient and may not be suitable for severe fluid overload.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">D.</span> </strong><strong><span style=\"font-size:12.0pt\">Sustained low-efficiency dialysis (SLED)</span></strong><span style=\"font-size:12.0pt\">: SLED is a hybrid modality but may not be tolerated in unstable patients</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">To understand the role of continuous renal replacement therapy (CRRT) as the preferred dialysis modality for hemodynamically unstable patients with acute kidney injury (AKI) and severe fluid overload. CRRT allows for gentle and continuous removal of fluids and solutes, minimizing the risk of hypotension compared to intermittent hemodialysis.</span></span></span></p>",
      "correct_choice_id": 81478,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20380,
      "choices": [
        {
          "id": 81481,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Severe hyperkalemia unresponsive to medical therapy </span></span></span></p>"
        },
        {
          "id": 81482,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Uremic pericarditis </span></span></span></p>"
        },
        {
          "id": 81483,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Severe fluid overload unresponsive to diuretics </span></span></span></p>"
        },
        {
          "id": 81484,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">BUN level of 120 mg/dL</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following is NOT an absolute indication for dialysis in AKI?</span></span></p>",
      "unique_key": "Q4397157",
      "question_audio": null,
      "question_video": null,
      "map_id": 20377,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. D) BUN level of 120 mg/Dl</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">While elevated BUN is a sign of AKI, it is not an absolute indication for dialysis in isolation. The decision to initiate dialysis depends on the clinical context and the presence of other complications.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Severe hyperkalemia unresponsive to medical therapy</span></strong><span style=\"font-size:12.0pt\">, <strong>Option&nbsp;</strong></span><strong><span style=\"font-size:12.0pt\">B. Uremic pericarditis&nbsp;</span></strong><span style=\"font-size:12.0pt\">and&nbsp;<strong>Option C. Severe fluid overload unresponsive to diuretics</strong>: These are all absolute indications for dialysis in AKI.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The absolute indications for dialysis in AKI, which include severe hyperkalemia unresponsive to medical therapy, uremic pericarditis, and severe fluid overload unresponsive to diuretics. Elevated BUN alone is not an absolute indication, and the decision to initiate dialysis should be based on the overall clinical context and the presence of life-threatening complications.</span></span></span></p>",
      "correct_choice_id": 81484,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}